Drug Profile
Fenofibrate - Shiner Pharm
Alternative Names: Lifenoz-ULatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Shiner Pharm Corp
- Class Antihyperlipidaemics; Benzophenones; Butyric acids; Fibric acid derivatives; Propionates; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus
Most Recent Events
- 13 Feb 2019 Chemical structure information added
- 12 Feb 2016 Launched for Type-2 diabetes mellitus in Taiwan (PO) before January 2016